We use cookies to provide you with a better experience. By clicking the Accept button, you are agreeing to our use of cookies in accordance with our Privacy Policy.
  • Patient Resources
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
    • Glossary
  • Professional Resources
    • Research Center Profiles
    • Industry Provider Profiles
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • Events
    • Newsletters
    • JobWatch
    • White Papers
    • Patient Education
    • SOPs
  • About Us
  • Contact Us
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » FDA’s Commissioner of Food and Drugs receives public service award

FDA’s Commissioner of Food and Drugs receives public service award

May 9, 2016
CenterWatch Staff

Robert M. Califf, M.D., the newly appointed FDA Commissioner of Food and Drugs, received the 2016 American Association of Clinical Endocrinologists’ (AACE) Eugene T. Davidson, M.D., Public Service Award.

The AACE Eugene T. Davidson, M.D., Public Service Award is presented to a health professional, organization or individual layperson for outstanding contributions to advancing the mission of AACE in providing quality health care for patients with endocrine diseases and for the betterment of public health.

As the top FDA official, Dr. Califf is responsible for strengthening programs and policies that enable the agency to carry out its mission to protect and promote public health.

“It’s an honor to receive the Frontiers in Science Award from AACE,” said Dr. Califf. “After a career of caring for patients with cardiovascular and metabolic disease and multiple opportunities to conduct clinical trials and health services research in patients with diabetes, I am keenly aware of the suffering caused by diabetes and the need to both develop new therapies and understand how to deploy older therapies. We take this very seriously at FDA.”

Previously, Dr. Califf served as the FDA’s Deputy Commissioner for Medical Products and Tobacco from February 2015 until his appointment as commissioner in February 2016. In that capacity, he provided executive leadership to the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Tobacco Products. He also oversaw the Office of Special Medical Programs and provided direction for cross-cutting clinical, scientific, and regulatory initiatives, including precision medicine, combination products, orphan drugs, pediatric therapeutics, and the advisory committee system.

A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf has led many landmark clinical trials and is a frequently cited author in biomedical science, with more than 1,200 publications in peer-reviewed literature.

United States Awards & Advancement

Upcoming Events

  • 16Dec

    Master the Regulatory Pathway for Cell & Gene Therapy Submissions: Strategies for Successful BLAs

Featured Products

  • Regenerative-medicine-steps-to-accelerate-development-pdf

    Regenerative Medicine: Steps to Accelerate Development — PDF

  • Clinical-trial-agreements-a-guide-to-key-words-and-phrases-pdf

    Clinical Trial Agreements: A Guide to Key Words and Phrases — PDF

Featured Stories

  • Ich_logo

    ICH Overhauls 22-Year-Old Clinical Studies Guideline

  • Survey_chart2019

    Sponsors, CROs Doing Better, Sites Say, But More Work Is Needed

  • China-360x240

    U.S. Tops List of Trial Startups With China Making Progress in Phase 1

  • Phoneapp-360x240

    Device Apps Present Unique Risks in Trials

New!

2019 Site Survey Reports

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2019. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing